These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17011346)

  • 1. Pediatricians' IQ on RDS, NAFLD, and syndrome X.
    Schwartz ID
    J Pediatr; 2006 Oct; 149(4):582-3; author reply 583. PubMed ID: 17011346
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic syndrome and nonalcoholic fatty liver diseases in children].
    Zakharova IN; Zvenigorodskaia LA; Iablochkova SV
    Eksp Klin Gastroenterol; 2011; (11):44-8. PubMed ID: 22629718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease: the hepatic metabolic syndrome.
    Page J
    J Am Acad Nurse Pract; 2012 Jun; 24(6):345-51. PubMed ID: 22672485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic fatty liver disease and metabolic syndrome: a concise review.
    Streba LA; Cârstea D; Mitruţ P; Vere CC; Dragomir N; Streba CT
    Rom J Morphol Embryol; 2008; 49(1):13-20. PubMed ID: 18273497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
    Rafiq N; Younossi ZM
    Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae.
    Karlas T; Wiegand J; Berg T
    Best Pract Res Clin Endocrinol Metab; 2013 Apr; 27(2):195-208. PubMed ID: 23731881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: Results from a population-based study.
    van der Voort EA; Koehler EM; Dowlatshahi EA; Hofman A; Stricker BH; Janssen HL; Schouten JN; Nijsten T
    J Am Acad Dermatol; 2014 Mar; 70(3):517-24. PubMed ID: 24373781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [NAFLD and metabolic syndrome a troublesome association].
    Reyes RB
    Rev Gastroenterol Mex; 2006; 71(4):510-1. PubMed ID: 17542287
    [No Abstract]   [Full Text] [Related]  

  • 10. [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers].
    Kieć-Wilk B; Klupa T; Dembińska-Kieć A
    Przegl Lek; 2010; 67(7):496-501. PubMed ID: 21387764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic characteristics and associated factors of nonalcoholic fatty liver disease diagnosed at medical checkups].
    Nah EH; Park JY
    Korean J Lab Med; 2008 Jun; 28(3):244-50. PubMed ID: 18594178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].
    Shi HB; Fu JF; Liang L; Wang CL; Zhu JF; Zhou F; Zhao ZY
    Zhonghua Er Ke Za Zhi; 2009 Feb; 47(2):114-8. PubMed ID: 19573457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.
    Moore JB
    Proc Nutr Soc; 2010 May; 69(2):211-20. PubMed ID: 20158939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.
    Akbar DH; Kawther AH
    Med Sci Monit; 2006 Jan; 12(1):RA23-6. PubMed ID: 16369477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome.
    Moscatiello S; Di Luzio R; Sasdelli AS; Marchesini G
    Expert Opin Pharmacother; 2011 Dec; 12(17):2657-72. PubMed ID: 22043839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between nonalcoholic fatty liver disease and metabolic syndrome.
    Chen SH; He F; Zhou HL; Wu HR; Xia C; Li YM
    J Dig Dis; 2011 Apr; 12(2):125-30. PubMed ID: 21401898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of nonalcoholic fatty liver disease unrelated to the metabolic syndrome.
    Yilmaz Y; Senates E; Ayyildiz T; Colak Y; Tuncer I; Ovunc AO; Dolar E; Kalayci C
    Eur J Clin Invest; 2012 Apr; 42(4):411-8. PubMed ID: 21913918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome and the liver.
    Verrijken A; Francque S; Van Gaal L
    Acta Gastroenterol Belg; 2008; 71(1):48-59. PubMed ID: 18396752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study.
    Salvi P; Ruffini R; Agnoletti D; Magnani E; Pagliarani G; Comandini G; Praticò A; Borghi C; Benetos A; Pazzi P
    J Hypertens; 2010 Aug; 28(8):1699-707. PubMed ID: 20467324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.
    Rahimi RS; Landaverde C
    Nutr Clin Pract; 2013 Feb; 28(1):40-51. PubMed ID: 23286927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.